Clinical protocol for a phase II double-blind evaluation of G-CSF vs the optimal schedule of SC-70935 in patients with breast cancer receiving chemotherapy with docetaxel, doxorubicin and cyclophosphamide (TAC)
View All Studies
Clinical protocol for a phase II double-blind evaluation of G-CSF vs the optimal schedule of SC-70935 in patients with breast cancer receiving chemotherapy with docetaxel, doxorubicin and cyclophosphamide (TAC)